ArticleEuropean journal of neurology2025

Real-life experience with disease-modifying drugs in hereditary transthyretin amyloid polyneuropathy: A clinical and electrophysiological appraisal.

Hadia Rebouh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.